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The observation that a high fat/low carbohydrate (CHO)
diet has a beneficial effect on a mouse model of Alzhe-
imer's disease (AD) published today is notable given pre-
vious results showing that high fat diets have a deleterious
effect on AD. Van de Auwera, et al. [1] reported that mice
fed a ketogenic diet (<1% carbohydrate, 80% fat) were
found to have a 25% decrease in the protein Aβ42 com-
pared to mice fed a standard high-carbohydrate, low-fat
chow diet. Aβ42 is a particularly amyloidogenic mutant
form of the amyloid precursor protein whose proteolytic
product β-amyloid peptide is contained in the plaques
and neurofibrillar tangles that are characteristic of AD.
Any suggestion of an environmental or dietary attack on
AD is welcome given the devastating effects of the disease.
Beyond the potential application, however, Van de Auw-
era, et al.'s results have general implications for nutritional
approaches in biochemistry and cell biology, and ulti-
mately on disease processes. The physiologic effect of die-
tary fat can be significantly modulated by the presence of
carbohydrate and the associated hormonal changes. The
description "high fat diet" is thus an inadequate way to
characterize a diet. One must also specify the level of
carbohydrate.
The principle that dietary fat might play a relatively pas-
sive role in metabolism and that the disposition of fat is
regulated by the hormonal state stimulated by carbohy-
drate is taught in elementary courses in biochemistry but
remains an under-appreciated factor in many studies, pos-
sibly due to the emphasis on low-fat recommendations of
nutritional agencies. Because of the requirement of brain
cells for glucose (or ketones) for energy metabolism and,
in particular, because of the known involvement of insu-
lin in regulating secretase (proteolytic enzyme in β-amy-
loid production) (e.g. [2]), it is pertinent to inquire about
the role of macronutrient composition in the diet in neu-
ronal disorders. The role of energy metabolism in brain
function has been discussed in a recent review and
hypothesis by Mukherjee and Seyfried [3].
In explaining the importance of macronutrient composi-
tion to students we emphasize energy metabolism and
gain or loss of body weight and we stress the need to get
away from the principle that "you are what you eat," and
replace it with the idea that "you are what you do with
what you eat [4]." A common analogy, that fat is the
bomb and carbohydrate is the fuse, or in its original
description, powder keg and tinder box, may be too broad
for appreciation of fine control of metabolism but is prob-
ably good enough to illustrate the principle here.
Although there are many effects of dietary change, to a
first order approximation, carbohydrate is the major stim-
ulus for insulin secretion and as an anabolic hormone,
leads to repression of lipolysis and glycogenolysis. Con-
tinued hyperinsulinemia, therefore, may predispose to a
state where dietary fat is stored rather than oxidized. In
addition, current thinking on insulin resistance empha-
sizes the role of free fatty acids and other fat metabolites
(e.g. [5,6]). One theory of the etiology of insulin resist-
ance is that insulin resistance in the adipocyte represents
down regulation of response due to continued hyperin-
sulinemia. This causes increased lipolysis and excessive
liberation of fatty acids which may have several effects in
peripheral tissues. Thus, the regulation of the TAG-fatty
acid axis may be more important than the dietary levels of
fat itself.
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Similarity of starvation and carbohydrate 
restriction
One of the areas bearing on the idea that disposition of fat
is controlled by insulin is the observation made by several
groups that the metabolic response to starvation resem-
bles the response to carbohydrate restriction [7-11]. An
important but, in our view, under-appreciated study is
that of Klein & Wolfe [11] who compared responses of
subjects on an 84 hour fast to the same subjects on a sim-
ilar fast in which lipids were infused at a level equal to
resting energy requirements. Table 1 shows that the levels
of fatty acid, rates of oxidation and levels of glucose and
ketone bodies were similar in the two groups (Table 1).
These rather dramatic results were summarized by the
authors as demonstrating that "carbohydrate restriction,
not the presence of a negative energy balance, is responsi-
ble for initiating the metabolic response to fasting." It
might be said that this is the key experiment in under-
standing the interaction between fat and carbohydrate.
Similarly, Bisschop, et al. [8] demonstrated a similarity
between high carbohydrate, low fat diets (CHO:Lipid:Pro-
tein = 85:0:15) and control (44:41:15) diets in FFA rate of
appearance and oxidation but significant differences with
a low carbohydrate, high fat diet (CHO:Lipid:Protein =
2:83:15).
High fat diets in obesity
The interaction of fat and carbohydrate bear on the mech-
anism of weight loss strategies based on carbohydrate
restriction. In considering the problem, it is important to
recognize that percentages are misleading. There are really
three degrees of freedom in design or analysis of a weight
loss experiment: two of the three macronutrients and the
total caloric intake. It is unlikely that the percentage rather
than the absolute amount of macronutrients is the con-
trolling variable and at least three published studies show
that carbohydrate reduction is not necessarily accompa-
nied by replacement with either fat or protein but rather
caloric reduction due to the carbohydrate removed [12-
14]. Such diets are effectively high fat by percentages but
lead to substantial weight loss.
To understand the relative impact of carbohydrate and fat,
one has to consider experiments in which one macronu-
trient is replaced by another. Several studies in the litera-
ture have demonstrated that in isocaloric comparisons,
the replacement of dietary carbohydrate with fat leads to
greater weight loss [15-19], that is, the absence of the fuse
prevents an explosive effect of dietary fat on body mass.
The limitations of the fat bomb per se are reviewed by Wil-
lett and Leibel [20].
Cardiovascular disease
Many of the objections over the years of controlling the
effect of dietary fat by replacing dietary carbohydrate has
centered on the "obvious" danger that high fat diets
present to plasma lipids and coronary risk. The subject is
more complicated than obesity in that the mechanistic
role of insulin is less well understood and the type of fat
becomes much more important. Moreover, the relative
importance of different risk factors LDL vs. triglycerides
and HDL may be a matter of clinical judgment. However,
what we know from epidemiology is that, whereas replac-
ing unsaturated fat (UF) with saturated fat is deleterious to
CVD outcome, replacing UF with carbohydrate is worse
[21]. Similar effects are seen on the effect of dietary
replacement on total cholesterol/HDL [22]. The generally
beneficial effects of carbohydrate reduction on lipid pro-
file has been reviewed by Volek [23].
Diabetes
Control of lipid metabolism by insulin is of greatest
importance in diabetes where insulin insufficiency or
resistance is the key variable. The subject is a matter of cur-
rent controversy since official organizations counsel
against high-fat diets: the American Diabetes Association
position statement, for example, presents an expert con-
sensus for 60–70% of energy intake as carbohydrates for
diabetics. Such high intake of the major insulin secreta-
gogue as a therapeutic strategy remains counter-intuitive
and may not even be known to or implemented by many
practicing physicians and the idea has recently been
strongly criticized [24,25].
A widely quoted example of experiments bearing on this
question is the study of Garg, et al. [26,27]. In a four-
center randomized crossover trial, carbohydrate was
replaced with monounsaturated fats (CHO: 55% → 40;
total fat: 30% → 45) or, conversely, MUF was replaced
with CHO. It was found that replacement of MUF with
Table 1: Similarity of starvation and carbohydrate restriction
Reference [11] FFA (µmol/l) fat oxidation (µmol/kg/min) Glucose (mg/dl) β-hydroxybutyrate (mM)
Fast 84 h 0.92 1.94 68 2.56
Fast + Lipid 1.02 1.67 66 2.54
Data from reference [11]. Procedure as described in the text.Nutrition & Metabolism 2005, 2:27 http://www.nutritionandmetabolism.com/content/2/1/27
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carbohydrate "caused persistent deterioration of glycemic
control and accentuation of hyperinsulinemia, as well as
increased plasma triglyceride and very-low-density lipo-
protein cholesterol levels, which may not be desirable
[26]," that is, the high fat arm was beneficial, again, sug-
gesting that what happened to the fat was more important
than its concentration in the diet.
To determine the relative importance of fat and carbohy-
drate and protein, Gannon and coworkers have measured
the effect of replacement of carbohydrate with protein and
fat in patients with type 2 diabetes [28]. Figure 1 shows
the effects on glycemic control of the replacement of car-
bohydrate with protein and fat. Again, the 50% fat diet
provides better glycemic control although, in this case, the
relative contributions of carbohydrate reduction and
increase in protein is unknown.
Conclusion
The long range implication of Van de Auwera's study for
AD remains to be seen but the general lesson is that in die-
tary recommendations or in testing animal models a diet
should not be characterized as high fat without also spec-
ifying the level of carbohydrate.
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low circles: (CHO:fat:protein = 55:30:15)) or 5 weeks on the 
higher fat diet (blue circles: (20:50:30)). Meals are Breakfast 
(B), lunch (L) and dinner(D) plus 2 snacks (S1, S2). Data from 
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